Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Short-Term and Long-Term Outcomes of a Vocational Rehabilitation Program for Patients with Acquired Brain Injury in The Netherlands.

van Dongen CH, Goossens PH, van Zee IE, Verpoort KN, Vliet Vlieland TPM, van Velzen JM.

J Occup Rehabil. 2018 Sep;28(3):523-530. doi: 10.1007/s10926-017-9738-6.

2.

Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells.

Gorges TM, Kuske A, Röck K, Mauermann O, Müller V, Peine S, Verpoort K, Novosadova V, Kubista M, Riethdorf S, Pantel K.

Clin Chem. 2016 Nov;62(11):1504-1515. Epub 2016 Sep 14.

3.

Clinical experience with Zarzio® in Europe: what have we learned?

Gascón P, Tesch H, Verpoort K, Rosati MS, Salesi N, Agrawal S, Wilking N, Barker H, Muenzberg M, Turner M.

Support Care Cancer. 2013 Oct;21(10):2925-32. doi: 10.1007/s00520-013-1911-7. Epub 2013 Aug 1. Review.

4.
5.

Efficacy and safety of irinotecan-based chemotherapy for advanced colorectal cancer outside clinical trials: an observational study.

Moehler M, Ababneh Y, Verpoort K, Schmidt B, Musch R, Soeling U, Maintz C, Siebler J, Schimanski CC, Galle PR, Fahlke J.

Onkologie. 2010;33(12):684-90. doi: 10.1159/000322208. Epub 2010 Nov 22.

PMID:
21124039
6.

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis.

van der Woude D, Rantapää-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, Drijfhout JW, Huizinga TW, Toes RE, Pruijn GJ.

Ann Rheum Dis. 2010 Aug;69(8):1554-61. doi: 10.1136/ard.2009.124537. Epub 2010 May 6.

PMID:
20448290
7.

The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis.

van der Woude D, Syversen SW, van der Voort EI, Verpoort KN, Goll GL, van der Linden MP, van der Helm-van Mil AH, van der Heijde DM, Huizinga TW, Kvien TK, Toes RE.

Ann Rheum Dis. 2010 Jun;69(6):1110-6. doi: 10.1136/ard.2009.116384. Epub 2010 May 3.

PMID:
20439289
8.

The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis.

Machold KP, Landewé R, Smolen JS, Stamm TA, van der Heijde DM, Verpoort KN, Brickmann K, Vázquez-Mellado J, Karateev DE, Breedveld FC, Emery P, Huizinga TW.

Ann Rheum Dis. 2010 Mar;69(3):495-502. doi: 10.1136/ard.2009.122473. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
20223838
9.

Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis.

Visser K, Verpoort KN, van Dongen H, van der Kooij SM, Allaart CF, Toes RE, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2008 Aug;67(8):1194-5. doi: 10.1136/ard.2008.088070. No abstract available.

PMID:
18621971
10.

Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.

de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.

Arthritis Rheum. 2008 May;58(5):1293-8. doi: 10.1002/art.23439.

11.

Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles.

Verpoort KN, Cheung K, Ioan-Facsinay A, van der Helm-van Mil AH, de Vries-Bouwstra JK, Allaart CF, Drijfhout JW, de Vries RR, Breedveld FC, Huizinga TW, Pruijn GJ, Toes RE.

Arthritis Rheum. 2007 Dec;56(12):3949-52.

12.

Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study.

Teng YK, Verburg RJ, Verpoort KN, Diepenhorst GM, Bajema IM, van Tol MJ, Jol-van der Zijde EC, Toes RE, Huizinga TW, van Laar JM.

Arthritis Res Ther. 2007;9(5):R106.

13.

Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles.

Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, Jol-van der Zijde CM, van Tol MJ, Drijfhout JW, Breedveld FC, de Vries RR, Huizinga TW, Toes RE.

Arthritis Rheum. 2007 Sep;56(9):2913-8.

14.

The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.

van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2007 Feb;56(2):425-32.

15.

Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.

Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA, Ioan-Facsinay A, Drijfhout JW, van Tol MJ, Breedveld FC, Huizinga TW, Toes RE.

Arthritis Rheum. 2006 Dec;54(12):3799-808.

16.

The effects of rituximab treatment during pregnancy on a neonate.

Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N.

Haematologica. 2006 Oct;91(10):1426-7. Epub 2006 Sep 7.

17.
18.

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.

van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW.

Arthritis Res Ther. 2005;7(5):R949-58. Epub 2005 Jun 14.

19.

Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.

Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2005 Oct;52(10):3058-62.

20.

Undifferentiated arthritis--disease course assessed in several inception cohorts.

Verpoort KN, van Dongen H, Allaart CF, Toes RE, Breedveld FC, Huizinga TW.

Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S12-7. Review.

PMID:
15552509
21.

Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancer.

Laack E, Dierlamm T, Knuffmann C, Popp J, Schmied B, Dürk H, Wacker-Backerhaus G, Zeller W, Verpoort K, Fiedler W, Kurt Hossfeld D.

Lung Cancer. 2002 Jun;36(3):303-7.

PMID:
12009242
22.

The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.

Gause A, Verpoort K, Roschansky V, Tschiersch A, Hasenclever D, Schmits R, Diehl V, Brosteanu O, Pfreundschuh M.

Ann Oncol. 1991 Sep;2(8):579-83.

PMID:
1724380
23.

Pretherapeutic drug testing in acute leukemias for prediction of individual prognosis.

Lathan B, von Tettau M, Verpoort K, Diehl V.

Haematol Blood Transfus. 1990;33:295-8. No abstract available.

PMID:
1691133

Supplemental Content

Loading ...
Support Center